Study of EBI-005 in Dry Eye Disease (DED)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a randomized, double masked study designed to evaluate the safety of EBI-005 5 mg/mL topical ophthalmic solution given three times daily (TID) compared to vehicle-control over a one year period in subjects with dry eye disease (DED). Approximately 188 subjects will be enrolled to either EBI-005 or vehicle at up to 15 centers in the United States (US) and Canada.
Epistemonikos ID: 5a3cd9d3aaac6d223211bb49307f9f67f5d37844
First added on: May 12, 2024